Navigation Links
Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Date:4/28/2008

2008 2007

Revenues:

Product sales $101,507 $87,152

Collaborative research revenue 2,459 2,352

Royalty and license revenue 18,597 11,547

Total revenues 122,563 101,051

Operating expenses:

Cost of product sales 32,636 29,160

Research and development 23,066 20,258

Marketing and sales 11,908 9,536

General and administrative 11,937 11,281

Total operating expenses 79,547 70,235

Income from operations 43,016 30,816

Interest income 4,207 2,675

Other income/(expense) 1,473 (130)

Total other income, net 5,680 2,545

Income before income tax 48,696 33,361

Income tax expense 16,751 11,886

Net income $31,945 $21,475

Net income per share:

Basic $0.59 $0.41

Diluted $0.58 $0.40

Weighted average shares outstanding:

Basic 53,796 52,170

Diluted 55,023 53,634

Gen-Probe Incorporated

Consolidated Statements of Cash Flows

(In thousands)


'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
2. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
3. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
4. Carl Hull Named President and Chief Operating Officer of Gen-Probe
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
6. Gen-Probe to Webcast Three Upcoming Presentations
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
9. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
10. CV Therapeutics Reports 2008 First Quarter Financial Results
11. Caliper Life Sciences Reports West Coast Consolidation of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... has just been added to the growing case ... the next big thing in the high-tech world ... An international collaboration of researchers led by a ... Lawrence Berkeley National Laboratory (Berkeley Lab) has reported ... in photo-excited MX2 materials. The recorded charge transfer ...
(Date:8/26/2014)... ALPHARETTA, Ga. , Aug. 26, 2014 /PRNewswire/ ... ambient biological sample collection, stabilization and transportation, announced ... with Laboratory Procurement Services, LLC (LPS) of ... ViveST line of products in the United ... a new class of ambient temperature dried biological ...
(Date:8/26/2014)... 2014 The global market for molecular ... 2020, according to a new study by Grand View ... and the subsequent introduction of advanced cancer diagnostic technologies ... over the next six years. Moreover, the growing global ... cancer, coupled with disease triggering lifestyle habits such as ...
(Date:8/26/2014)... , Aug. 26, 2014 Trovagene, ... Next Generation Dx Summit; Moving Assays to the ... Detection and Monitoring of Cell Free Tumor DNA ... analytical component of its Precision Cancer Monitoring (PCM) ... clinical sensitivity for the detection of tumor DNA ...
Breaking Biology Technology:Competition for graphene 2ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... Pharma S.A., a,global specialty pharmaceutical company focused ... company, Galderma Laboratories, Inc., has,completed its acquisition ... result of the transaction, CollaGenex has become ... "We are pleased to complete the acquisition ...
... Signalife, Inc.,(Amex: SGN ) has confirmed that ... and Chief Executive Officer, Dr. Lowell T. Harmison, has,scheduled ... EDT., Dr. Harmison stated: "Now that Signalife has ... manufacturing and shipping,product, I am pleased to provide direction ...
... April 11 Dilon Technologies, Inc., a,manufacturer and ... nine additional Dilon 6800 orders have been secured ... The Dilon 6800, a high-resolution, small field-of-view ... a molecular,breast imaging technique used for the early ...
Cached Biology Technology:Galderma Completes Acquisition of CollaGenex 2Galderma Completes Acquisition of CollaGenex 3Galderma Completes Acquisition of CollaGenex 4Signalife Announces Webcast 2Signalife Announces Webcast 3
(Date:8/27/2014)... Ebola is a rare, but deadly disease that exists ... One of the most lethal strains is the Sudan ... Africa, SUDV has caused widespread illness, even as recently ... journal ACS Chemical Biology , researchers now report ... infected with SUDV. , John Dye, Sachdev Sidhu, Jonathan ...
(Date:8/27/2014)... Outstanding basic research, a growing focus on ... patient care have earned the Herbert Irving Comprehensive ... (CUMC) and NewYork-Presbyterian Hospital an $18 million, five-year ... Institute (NCI). The grant renews the center,s status ... Centers in New York City and one of ...
(Date:8/27/2014)... shown that excessive iron is closely associated ... studies from Chunyan Guo and co-workers from ... that baicalin prevented iron accumulation after substantia ... expression, and increased ferroportin 1 expression in ... rats. However, the relationship between iron concentration ...
Breaking Biology News(10 mins):Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4
... team led by British Antarctic Surveys (BAS) Dr Andy Smith ... ice sheet. The lake the size of Lake Windermere ... climate change and future sea-level rise. Glaciologist Dr Smith ... are camped out at one of the most remote places ...
... implications. Should children be tested for gene mutations ... cancer later in life" New research suggests ... even when any steps to reduce that risk will ... current policies., In the study published today online in ...
... PHILADELPHIA - University of Pennsylvania engineers and physicians have ... a human hair that measures electric current and delivers ... tool to probe cells with minimal intrusion and inject ... are found in almost every cell laboratory in the ...
Cached Biology News:Exploration of lake hidden beneath Antarctica's ice sheet begins 2Should children be permitted to get genetic testing for BRCA 1/2 mutations? 2Penn engineers create carbon nanopipettes that are smaller than cells and measure electric current 2
Anti-Mouse Qa.m8, Ascites (Clone 5035-24.1) (mouse IgG3)...
... contains 4 deuterium atoms at the 9, 10, ... use as an internal standard for the quantification ... is produced by incubation of linoleic acid with ... to inhibit the adhesion of tumor cells to ...
...
...
Biology Products: